NCI Community Cancer Centers Program Pilot: Questions and Answers
1. Why is the National Cancer Institute (NCI) conducting the NCI Community Cancer Centers Program pilot?
Evidence from a wide range of studies suggests that cancer patients diagnosed and treated in a setting of multispecialty care and clinical research may live longer and have a better quality of life. The NCCCP pilot will offer more Americans access to research-based cancer care by affiliating with the hospitals and clinics where most cancer patients already receive care. The pilot will make it easier to receive high-quality cancer screening, early detection, treatment, and palliative care services. This is expected to improve treatment outcomes for more Americans.
2. Why is NCI expanding its programs into the community?
NCI estimates that 85 percent of cancer patients in the United States are diagnosed at hospitals in or near the communities in which they live. The other 15 percent are diagnosed at NCI-designated Cancer Centers, a network of 63 academic research institutions located in largely urban areas across the country. Many patients are not treated at the major cancer centers because of distance, or for personal or economic reasons. The NCCCP pilot will extend NCI programs into local communities, giving patients easier access to clinical research and advanced care.
3. What are the goals of the NCCCP pilot?
The goals of the NCCCP pilot are to:
- Expand clinical trials. Pilot-site patients will have access to the very latest cancer prevention and treatment advances through NCI-sponsored clinical trials. Pilot sites will provide a local point of entry to draw more patients into clinical trials and enable researchers to more rapidly develop and evaluate effective prevention and treatment strategies.
- Reduce cancer healthcare disparities. A major focus of the NCCCP is on reducing the cancer burden among underserved populations. The NCCCP will actively reach out to these communities, bringing more Americans into the system of care and helping NCI to better understand and address the root causes of disparities.
- Provide voluntarily obtained patient data and samples needed for research. With access to a broader cross section of patients who voluntarily provide tissue and blood samples, researchers will have greater opportunity to study both normal and cancerous cells. The pilot will assess how NCI's guidelines for collection and storage of specimens can be applied nationwide to benefit the entire cancer research community.
- Explore the utility of a national database of voluntarily-provided electronic medical records. The pilot will assess the ability of sites to link medical information, provided with patient consent, to NCI's electronic patient data repository, Cancer Biomedical Informatics GridTM (caBIGTM). Expanding the amount of patient data available to cancer researchers will greatly contribute to our knowledge and treatment of cancer.
4. How does the NCCCP pilot compare to other NCI community cancer initiatives?
The NCCCP shares many of the same goals as other NCI community cancer programs, including increasing access to clinical trials among underserved populations, and reducing health disparities. The NCCCP is unique in that it will operate in community hospitals in geographically diverse areas where NCI can learn directly from the communities it serves.
5. What are the expected benefits to patients?
The sites will provide patients with comprehensive cancer screening, prevention, treatment, and palliative care. Patients diagnosed with cancer will receive medical, surgical, and radiation oncology services and will have access to NCI-sponsored clinical trials. In addition, NCI-trained patient navigators will assist patients in arranging financial support, scheduling transportation services, coordinating records transfers, and other services.
6. What are the expected benefits to participating hospitals and communities?
The pilot is expected to improve quality of care at the sites by enhancing clinical research expertise. In addition, the pilot sites will benefit from staff training in cancer management, stronger links to NCI-designated Cancer Centers, genetic and molecular testing capabilities, and outreach support to develop closer ties to underserved populations.
7. Where are the pilot sites and how will they be evaluated?
The pilot sites are community hospital-based cancer centers that offer medical, surgical, and radiation oncology care, see more than 1,000 new cancer cases each year, conduct and accrue to clinical trials, and conduct outreach to underserved populations. Evaluation will be conducted on an ongoing basis by an independent committee. NCI will use recommendations to refine the program and open the way for a national network of community cancer centers in the future.
The hospitals, their locations, and their cancer centers are:
- Billings Clinic, Billings, Mont. (Billings Clinic Cancer Center)
- Hartford Hospital, Hartford, Conn. (Helen & Harry Gray Cancer Center)
- St. Joseph's / Candler, Savannah, Ga. (Nancy N. and J.C. Lewis Cancer & Research Pavilion)
- Our Lady of the Lake Regional Medical Center, Baton Rouge, La. (Our Lady of the Lake Cancer Center and Mary Bird Perkins Cancer Center)
- Sanford USD Medical Center, Sioux Falls, S.D. (Sanford Cancer Center)
- Spartanburg Regional Hospital, Spartanburg, S.C., (Gibbs Regional Cancer Center)
- St. Joseph Hospital, Orange, Calif. (St. Joseph Hospital Cancer Center)
- Christiana Hospital, Newark, Del. (Helen F. Graham Cancer Center at Christiana Care)
- Ascension Health of St. Louis, Mo., for the following hospitals:
- St. Vincent Indianapolis Hospital, Indianapolis, Ind. (St. Vincent Oncology Center)
- Columbia St. Mary's, Milwaukee, Wis. (Columbia St. Mary's Cancer Center)
- Brackenridge Hospital, Austin, Texas (Shivers Center)
- Catholic Health Initiatives of Denver, Colo., for the following hospitals:
- Penrose-St. Francis Health Services, Colorado Springs, Colo. (Penrose Cancer Center)
- St. Joseph Medical Center, Towson, Md. (St. Joseph Cancer Institute)
- A coordinated regional program in Nebraska sponsored by Good Samaritan Hospital in Kearney (Good Samaritan Cancer Center); St. Elizabeth Regional Medical Center in Lincoln (St. Elizabeth Cancer Center); and St. Francis Medical Center in Grand Island (St. Francis Cancer Treatment Center).
For a press release on the NCCCP, please go to
For more information about cancer, please visit the NCI Web site at http://www.cancer.gov, or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
Back to Top